Xeureka Inc. uses the latest computational technology,
including cutting-edge AI and simulations,
to improve the efficiency and success rate of drug discovery research.
Ultimately, we aim to contribute to the swift,
economical delivery of effective medicines to patients suffering from disease.
In addition to analysis and screening services, we plan to sell software and provide SaaS in the future.
Please contact us to discuss how we can customize a solution to meet your needs, including the establishment of a computing environment.
Xeureka provides solutions for drug discovery research in the areas of both the Dry (computational) and Wet (experimental) drug discovery.
We will develop further value-added services in collaboration with external partners that can provide significant experimental technology capabilities.
NEWSMitsui & Co. Subsidiary, Xeureka, Launches Tokyo-1 Project Propelling AI-Driven Drug Discovery
BLOG【Case study】Ultra Large Scale Virtual Screening
NEWSXeureka Accelerates AI Drug Discovery with Cutting-edge Supercomputer Powered by NVIDIA, Launches Tokyo-1 Project for Leading Pharmaceutical Companies in Japan